Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative
Tóm tắt
Tài liệu tham khảo
10.1016/S0140-6736(05)67889-0
10.1002/gps.1652
10.1212/WNL.56.9.1143
Morris JC, 1999, Alzheimer's Disease, 11
Cummings JL, 2002, Definitions and diagnostic criteria S. Gauthier. Clinical Diagnosis and Management of Alzheimer's Disease, 3
10.1016/j.neurobiolaging.2007.02.016
10.1016/j.jalz.2011.03.005
10.1016/j.jalz.2011.03.008
10.1016/S1474-4422(10)70223-4
10.1016/j.jalz.2011.03.003
10.1016/j.jalz.2011.03.008
Fishman RA, 1992, Cerebrospinal fluid in diseases of the nervous system
10.1097/01.wad.0000194014.43575.fd
10.1159/000311703
10.1111/j.1600-0447.1993.tb03443.x
10.1002/1531-8249(200009)48:3<402::AID-ANA23>3.0.CO;2-G
10.1001/jama.289.16.2094
10.1002/emmm.200900048
10.1016/S0009-8981(03)00121-9
The Ronald and Nancy Reagan Research Institute of the Alzheimer's Association of the National Institute on Aging Working Group, 1988, Consensus Report of the Working Group on Molecular and Biochemical Markers of Alzheimer's Disease, Neurobiol Aging, 19, 109
10.1016/S1474-4422(03)00530-1
10.1016/S0361-9230(03)00086-8
10.1212/01.WNL.0000123249.58898.E0
10.1016/j.neurobiolaging.2008.10.017
10.1212/WNL.0b013e31821ccc98
10.1212/01.WNL.0000140289.18472.15
10.1212/01.WNL.0000140290.80962.BF
10.1002/ana.21610
10.3233/JAD-2010-101422
10.1001/archneurol.2009.316
10.1159/000313534
10.1001/jama.1996.03530310034029
10.1111/j.1468-1331.2009.02753.x
10.3109/13506120009146438
10.1093/clinchem/47.10.1776
10.1212/WNL.0b013e3181c47cc2
10.1038/nrneurol.2010.4
10.1016/j.sleep.2007.11.002
10.1212/01.wnl.0000256043.50901.e3
10.1002/ana.21623
MBjerke EPortelius LMinthon AWallin HAnckarsäter RAnckarsäter et al.Confounding factors influencing amyloid beta concentration in cerebrospinal fluid.Int J Alzheimers Dis2010 pii: 986310
DSlats.Hour‐to‐hour variability CSF biomarkers in AD patients. Presented at the Alzheimer's Association International Conference on Alzheimer's Disease (AAICAD) July 10–15 2010 Honolulu Hawaii.
10.2174/157488908784534595
Vanderstichele H, 2008, BioMarkers for Early Diagnosis of Alzheimer's Disease, 81
10.1001/archneur.56.6.673
10.1373/clinchem.2005.058776
APerret‐Liaudet MPelpel SLehmann SSchraen HVanderstichele IQuadrio et al.Sampling tube a critical factor in Alzheimer Disease Biomarker Standardization. Hot topics in International Conference on Alzheimer's Disease July 10–15 2010 Honolulu Hawaii.
10.1016/j.cca.2010.07.019
10.1385/NCC:4:2:153
10.1054/jocn.1999.0193
CETeunissen NAVerwey MIKester KvanUffelen MABlankenstein.Standardization of assay procedures for analysis of the CSF biomarkers amyloid β(1‐42) tau and phosphorylated tau in Alzheimer's disease: report of an International Workshop.Int J Alz Dis2010
Zimmerman R, 2011, Preanalytical sample handling and sample stability testing for the neurochemical dementia diagnosis, J Alz Dis, 25, 739
10.1002/pmic.200402039
10.1373/clinchem.2004.039735
10.1515/CCLM.2007.160
10.1002/ana.1032
10.1002/elps.200305992
10.1002/prca.200700126
10.1002/prca.200700330